In the December 2014 issue, the article “Celgene wagers on Sutro's cell-free platform to ramp up ADCs” incorrectly specified “ADCs” in the title, rather than “bispecifics.” The error has been corrected in the HTML and PDF versions of the article.

In the January 2015 issue, in the article “Foundation receives $3. 3-billion windfall for Kalydeco,” Howard Fillit's affiliation was given as the Alzheimer's Disease Research Foundation instead of the Alzheimer's Drug Discovery Foundation. The error has been corrected in the HTML and PDF versions of the article.